Alg13 | asparagine-linked glycosylation 13
Physiological systems
17 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Immune system Adipose tissue Growth/size/body region Hematopoietic system Skeleton
12 No significant impact
7 Not tested
Data collections
Gene metrics:7Significant phenotypes
3Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
decreased lean body mass | 2 supporting datasets | Alg13tm1a(KOMP)Wtsi | homozygote | Early adult | 1.25x10-8 | ||
decreased bone mineral content | 2 supporting datasets | Alg13tm1a(KOMP)Wtsi | homozygote | Early adult | 2.66x10-11 | ||
decreased bone mineral density | 1 supporting dataset | Alg13tm1a(KOMP)Wtsi | homozygote | Early adult | 1.11x10-15 | ||
increased total body fat amount | 2 supporting datasets | Alg13tm1a(KOMP)Wtsi | homozygote | Early adult | 3.29x10-9 | ||
increased leukocyte cell number | 1 supporting dataset | Alg13tm1a(KOMP)Wtsi | homozygote | Early adult | 2.53x10-6 |
| | | | | | | | | |
External links
No external links available for Alg13.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Alg13tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Alg13tm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell mouse |
Alg13tm1e(KOMP)Wtsi | Targeted, non-conditional allele | | ES Cell |